IBA: Advancing Cancer Treatment Through Innovative Particle Accelerator Technology
IBA, or Ion Beam Applications, is a leader in particle accelerator technology, focusing on advancing cancer treatment through innovative solutions like proton therapy. With over 60 centers worldwide, IBA is dedicated to improving patient outcomes and enhancing safety in medical applications. Their commitment to research and development, including the integration of AI in dosimetry, showcases their drive to push the boundaries of science for better healthcare. IBA’s initiatives align with global sustainability goals, making a significant impact on health and well-being.